Furcation involvement is a common sequela of severe chronic periodontal disease. Its effective management has a profound influence on the outcome of periodontal therapy.
INTRODUCTION
DEFINITION
TYPES OF TRAUMA FROM OCCLUSION
GLICKMAN CONCEPT
WAERHAUG CONCEPT
STAGES OF TISSUE RESPONSE TO INJURY
CLINICAL AND RADIOGRAPHIC FEATURES OF TFO
CLINICAL DIAGNOSIS OF TFO
TFO AND IMPLANTS
TREATMENT OF TFO
CONCLUSION
REFRENCES
Furcation involvement is a common sequela of severe chronic periodontal disease. Its effective management has a profound influence on the outcome of periodontal therapy.
INTRODUCTION
DEFINITION
TYPES OF TRAUMA FROM OCCLUSION
GLICKMAN CONCEPT
WAERHAUG CONCEPT
STAGES OF TISSUE RESPONSE TO INJURY
CLINICAL AND RADIOGRAPHIC FEATURES OF TFO
CLINICAL DIAGNOSIS OF TFO
TFO AND IMPLANTS
TREATMENT OF TFO
CONCLUSION
REFRENCES
A brief description of all topics to recent advances,SDD, host modulation and diabetes, host modulation in smokers, chemically modified tetracyclines, bisphosphonates
Phase I periodontal therapy is the first in the chronologic sequence of procedures that constitute periodontal treatment. It is also referred to as cause related therapy or non-surgical periodontal therapy.
Dentists play an important role in the diagnosis and management of desquamative gingivitis. The importance of being able to recognise and properly diagnose this condition is accentuated by the fact that a serious and life threatening disease may initially manifest as desquamative gingivitis.
A brief description of all topics to recent advances,SDD, host modulation and diabetes, host modulation in smokers, chemically modified tetracyclines, bisphosphonates
Phase I periodontal therapy is the first in the chronologic sequence of procedures that constitute periodontal treatment. It is also referred to as cause related therapy or non-surgical periodontal therapy.
Dentists play an important role in the diagnosis and management of desquamative gingivitis. The importance of being able to recognise and properly diagnose this condition is accentuated by the fact that a serious and life threatening disease may initially manifest as desquamative gingivitis.
Systemic Peridoontology, link between systemic health and periodontology, diabetes and periodontology, Pregnancy and Peridotology,Nutrition and periodontology
THE EFFECTS OF LOW GLYCEMIC INDEX FOODS ON THE POLYCYSTIC OVARIAN SYNDROME.pptxNabanitaDas33
Recent studies have shown that a low-carbohydrate, ketogenic diet can lead to
weight loss and improvements in insulin resistance cause weight loss and improving
insulin resistance may be beneficial for PCOS, we performed this pilot study using a
LCKD (Low-carbohydrate ketogenic diet) in women with PCOS. Together, the
analyzed data indicate that proper control of carbohydrate intake provides beneficial effects
on some aspects of PCOS and may represent one of the important interventions improving
the clinical symptoms of affected patients.
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
Periodontitis as a risk factor for Diabetes mellitus and Pre-term low birth weight
1. Periodontitis as a risk factor for Diabetes
mellitus and Pre-term low birth weight
Department of Periodontology and Oral implantology
Presented by :
Sushant Pandey
653
Resource faculties :
Dr. Shivalal Sharma
Dr. Khushboo Goel
Dr. Sajeev Shrestha
Dr. Pujan Acharya
2. Objectives :
1. Bi-directional relationship between periodontitis
and diabetes
2. Relationship between periodontitis and pre-term
low birth weight
3. Introduction :
Risk factors : They are environmental, behavioral, or biologic
factors that, when present, increase the likelihood that an
individual will develop the disease.
Risk factors for periodontal disease are
• Tobacco smoking
• Diabetes
• Pathogenic bacteria
• Microbial tooth deposits
4. International Diabetes Federation (IDF) describes diabetes
as a chronic disease that arises when the pancreas does not
produce enough insulin, or when the body cannot effectively
use the insulin it produces.
Types :
1. Type I diabetes (due to autoimmune β-cell destruction,
usually leading to absolute insulin deficiency)
2. Type 2 diabetes (due to a progressive loss of β-cell insulin
secretion frequently on the background of insulin
resistance)
3. Gestational diabetes mellitus
4. Diabetes due to other causes
5. In 2017,
• Approximately 425 million adults (20-79 years) were living with
diabetes
• The proportion of people with type 2 diabetes is increasing in most
countries
• 79% of adults with diabetes were living in low- and middle-income
countries
• 1 in 2 (212 million) people with diabetes were undiagnosed
• Diabetes caused 4 million deaths
• More than 1,106,500 children were living with type 1 diabetes
Source : International Diabetes Federation (IDF)
Facts and Figures
7. 1. Retinopathy
2. Neuropathy
3. Nephropathy
4. Cardiovascular diseases
5. Impaired wound healing
6. Periodontal disease
Complications of Diabetes :
Susceptibility to periodontitis is increased by approximately
three folds in people with diabetes.
8. Effects of diabetes on periodontium :
• Enlarged gingiva
• Sessile or pedunculated gingival polyps
• Polypoid gingival proliferations
• Abscess formation
• Periodontitis
• Loosened teeth
12. Bacterial pathogens
• Increased glucose in gingival fluid changes the
microflora.
• Patients with diabetes have a subgingival flora of
Capnocytophaga, anaerobic vibrios,
Actinomyces species, P.gingivalis
Interaction of any of these bacterial products with phagocytic
cells results in activation of a catabolic inflammatory cascade,
with synthesis and secretion of mediators including primarily
IL-lß, PGE2, TNF-α, and IL-6.
13. Polymorphonuclear leukocyte function
• Impaired chemotaxis & adherence
• Defective Phagocytosis
Diminished primary defense against periodontal
pathogens.
14. Altered Collagen Metabolism
Increased collagenase activity and decreased
collagen synthesis is seen in individuals with poorly
controlled diabetes.
Production of advanced glycation end products
(AGEs).
15. ADVANCED GLYCATION END PRODUCTS (AGEs)
AGEs are formed by the
non-enzymatic glycation
(addition of hexoses) to
proteins or lipids under
hyperglycaemic conditions.
16. AGEs
Plays central role in diabetic complications
Collagen is crosslinked by AGE, making it less soluble and
less likely to be replaced or repaired.
Cellular migration through crosslinked is impeded.
Binding of the AGE to macrophage receptor
(RAGE) initiates a cycle of cytokine upregulation,
with synthesis mostly of IL-1 and TNFα.
17.
18. Effects of periodontal diseases on the
diabetic state
The presence of periodontitis increases the risk of worsening
of glycemic control over time.
Incidences of macroalbuminuria and end-stage renal disease are
increased twofold and threefold, respectively, in diabetic individuals who
also have severe periodontitis compared to diabetic individuals without
severe periodontitis. Furthermore, the risk of cardiorenal mortality
(ischaemic heart disease and diabetic nephropathy combined) is three
times higher in diabetic people with severe periodontitis than in diabetic
people without severe periodontitis.
19. Bacterial infection causes increased secretion of
TNF-α and IL-lβ which in turn induce insulin
resistance and decrease insulin action.
22. Effect of periodontal treatment on diabetes
Limited evidence.
Meta-analyses indicate that HbA1c reductions of around
0.4% can be anticipated following effective periodontal
therapy.
24. • Preterm birth is the birth of a baby of less than 37
weeks gestational age.
• Low birth weight refers to infants who weigh less
than 2500 gm at birth.
• Low birth babies are 40 times more likely to die
in neonatal period than normal-birth weight
babies
25. The primary cause of LBW is preterm labor.
Women with preterm labor have culture-positive
amniotic fluid and bacteria most often isolated are
Fusobacterium nucleatum and Capnocytophaga.
These species are rarely found in female
reproductive tract but are common in oral cavity.
Spread of Infection is via hematogenous route
26. These bacteria stimulate cytokine production like IL-1
and TNFα and increase prostaglandin production in
amnion which leads to preterm delivery.
27.
28.
29. Summary
People with poorly controlled diabetes (both type 1 and type 2 diabetes
mellitus, both adults and children) must be considered at risk for
periodontitis, and people with diabetes should be informed of this risk.
Early diagnosis and prevention are of fundamental importance to avoid the
largely irreversible tissue loss that occurs in periodontitis.
Healthy periodontium is a must during pregnancy.
30. References :
1. Caranza’s clinical periodontology 12th edition
2. Periodontal Disease and Diabetes Mellitus: A Two-Way Relationship,
Sara G. Grossi and Robert J. Genco
3. Periodontitis and diabetes: a two-way relationship : P. M. Preshaw &
A. L. Alba & D. Herrera & S. Jepsen & A. Konstantinidis & K.
Makrilakis & R. Taylor
4. Associations between periodontal diseases and systemic diseases: A
review of the inter-relationships and interactions with diabetes,
respiratory diseases, cardiovascular diseases and osteoporosis : Lan-
Chen Kuo, Alan M. Polson, Taeheon Kang